In this sense, delicately designed drugs that specifically inhibit the AMPK α1, but not the α2, isoform might be helpful to selectively enhance adaptive thermogenesis and at the same time circumvent the hypoglycemia issue. Here, PRKAA1 is linked to Hypoglycemia.